Brazilian mega-mergers are on the rise, with deals nearly quadrupling to US$34 billion since last year, Bloomberg News reported on Monday, June 14.
Meanwhile, stock issuance by companies in Brazil leaped 83% to 69.6 reais, or US$13.6 billion, with firms raising capital in public equity markets and seeking out targets for takeover.
“Companies in Brazil are offering more shares on public markets as interest rates below inflation push many investors in search of higher yields,” stated the Bloomberg report. “At the same time, the COVID-19 pandemic has cut revenue at small firms, increasing acquisition opportunities for their bigger rivals.”
Alexandre Bertoldi, a partner at the law firm Pinheiro Neto Advogados, told Bloomberg that many companies in Brazil are flush after selling stock, and are using this as an opportunity to consolidate.
Bertoldi’s firm is one of the country’s leading advisors to companies looking to merge. It helped to oversee this year’s biggest transaction, the US$10.6 billion merger between the healthcare company Hapvida Participacoes e Investimentos SA and Notre Dame Intermedica Participacoes SA.
What’s happening in Brazil is part of a record wave of mergers and acquisitions around the world. As PYMNTS reported Brazilian mega-mergers are on the rise, this trend stems from low interest rates, rising stock prices and an uptick in interest in sectors that performed well during the COVID pandemic. $532 billion in deals were announced in May, the most ever for that month.
The total value of pending and completed deals in the first five months of the year hit $2.4 trillion, $1.3 trillion of which happened in the U.S. alone.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI